# Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy

> **NCT04487145** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 194 (actual)

## Conditions studied

- Drug-Drug Interaction
- HIV Infection

## Interventions

- **DRUG:** Dihydroartemisinin-piperaquine

## Key facts

- **NCT ID:** NCT04487145
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-23
- **Primary completion:** 2022-04-11
- **Final completion:** 2022-04-11
- **Target enrollment:** 194 (ACTUAL)
- **Last updated:** 2025-03-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04487145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04487145, "Dihydroartemisinin-Piperaquine in the Context of Antiretroviral Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04487145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*